{"nct_id":"NCT05564052","title":"A Study of Ibrutinib With Rituximab in Relapsed or Refractory Mantle Cell Lymphoma","status":"COMPLETED","status_verified_date":"2025-09","start_date":"2022-12-06","start_date_type":"ACTUAL","primary_completion_date":"2023-12-06","primary_completion_date_type":"ACTUAL","completion_date":"2024-09-26","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["JNJ"]}